Regulatory note: All qualification information reflects Florida Statute 381.986 and current OMMU guidance as of March 2026. Verify current qualifying conditions at knowthefactsmmj.com and leg.state.fl.us.

Does Epilepsy Qualify for a Florida MMJ Card?

✓

Yes — epilepsy and seizure disorders are explicitly listed under FL Statute 381.986

Epilepsy is named as a qualifying condition in Florida's medical marijuana statute. All documented seizure disorders qualify — generalized, focal, treatment-resistant, and pediatric epilepsy syndromes. A Florida-licensed physician confirms your diagnosis documentation and completes your OMMU certification at your Miracle Leaf evaluation appointment.

Epilepsy was among the primary conditions that drove Florida's original medical marijuana legislation, particularly given the evidence around CBD and seizure reduction in treatment-resistant pediatric epilepsy syndromes. The law explicitly covers epilepsy and extends to all seizure conditions "of the same kind or class" — meaning no seizure disorder is excluded by type.

Which Seizure Types and Epilepsy Syndromes Qualify

Florida Statute 381.986 lists epilepsy and seizures, and the "same kind or class" provision ensures all documented seizure disorders are covered. Here are the most common types seen at Miracle Leaf:

✓ Covered
Generalized epilepsy
Including tonic-clonic (grand mal), absence (petit mal), myoclonic, atonic, and tonic seizures. Generalized epilepsy involving both hemispheres from the onset qualifies directly.
✓ Covered
Focal (partial) epilepsy
Including focal aware, focal impaired awareness, and focal to bilateral tonic-clonic seizures. Temporal lobe epilepsy, frontal lobe epilepsy, and other localization-related epilepsies all qualify.
✓ Covered
Treatment-resistant epilepsy
Patients who have failed two or more appropriate AED trials — whether due to inadequate seizure control or intolerable side effects — qualify under this category. Bring documentation of prior medications tried and failed.
✓ Covered
Dravet syndrome
A severe treatment-resistant pediatric epilepsy syndrome. CBD-based treatment was FDA-approved for Dravet syndrome in 2018. Florida's MMJ program covers this and similar severe childhood epilepsy syndromes.
✓ Covered
Lennox-Gastaut syndrome
A severe treatment-resistant epilepsy syndrome with multiple seizure types. FDA-approved CBD treatment exists for LGS. Qualifies under both epilepsy listing and the "same kind or class" provision.
✓ Covered
Other seizure disorders
West syndrome, Tuberous sclerosis complex-related epilepsy, CDKL5 deficiency disorder, and other documented seizure conditions — all qualify under the "same kind or class" provision of Florida Statute 381.986.

The Pediatric and Caregiver Pathway

Florida's MMJ program allows minors with qualifying conditions to participate through a registered caregiver — typically a parent or legal guardian. Pediatric epilepsy was central to Florida's original medical marijuana advocacy, and the caregiver pathway exists specifically to serve these patients.

  • Caregiver registration: A parent or legal guardian registers with the OMMU as the minor's caregiver. The caregiver — not the minor — is the registered patient who purchases from licensed dispensaries.
  • Physician evaluation: The certifying physician evaluates the minor's epilepsy diagnosis and medical records, and enters the certification under the caregiver's OMMU registration.
  • Purchasing: The registered caregiver presents their caregiver ID at any licensed Florida dispensary to purchase approved products for the minor patient.
  • Approved delivery methods: For pediatric patients, the physician typically focuses on non-smokable delivery methods — tinctures, oils, and capsules — that are appropriate for the patient's age and clinical situation.
Parents of children with epilepsy
Call Miracle Leaf at (561) 888-6111 before your appointment to discuss the caregiver registration process. Bring your child's neurology records and their most recent AED medication list. Our physician is experienced with pediatric epilepsy cases and can walk you through both the clinical and OMMU registration steps.

What Documentation Epilepsy Patients Need

✓
Neurology records documenting your epilepsy diagnosis
Records from your neurologist or treating physician confirming your epilepsy or seizure disorder — including seizure type, frequency, and date of diagnosis. Your most recent neurology visit note is typically sufficient. EEG or imaging reports are helpful but not always required.
✓
Current antiepileptic drug (AED) list
A complete list of your current AEDs — including drug names, doses, and how long you have been on each. This is critical for epilepsy patients because cannabis — particularly CBD — can interact with certain AEDs in clinically significant ways. Your physician reviews this at your evaluation.
✓
Prior medications tried and failed (for treatment-resistant epilepsy)
If you have treatment-resistant epilepsy, bring documentation of prior AEDs tried and discontinued — either due to inadequate seizure control or intolerable side effects. This history strengthens the clinical case for MMJ certification.
✓
Valid Florida driver's license or state-issued ID
Required for OMMU registry enrollment. For caregiver registrations (pediatric patients), the caregiver's Florida ID is used for registration. Call us in advance if you are registering as a caregiver for a minor.

AED Medication Interactions — Critical for Epilepsy Patients

Cannabis — and CBD in particular — can interact with certain antiepileptic drugs in ways that affect both seizure control and medication side effects. This is one of the most important clinical considerations for epilepsy patients getting certified, and it is a core part of your Miracle Leaf evaluation.

CBD increases serum levels of clobazam. CBD is a known inhibitor of CYP2C19, the enzyme responsible for metabolizing clobazam (Onfi) and its active metabolite norclobazam. Patients taking clobazam who add CBD may experience increased clobazam levels — which can both improve seizure control and increase sedation-related side effects. Your physician and neurologist should both be aware of this interaction. Do not adjust your AED doses without consulting your neurologist.

Other clinically relevant interactions your physician will review at your evaluation:

  • Valproate (Depakote): CBD may increase valproate levels and the risk of valproate-related liver toxicity. Liver function monitoring may be recommended.
  • Stiripentol (Diacomit): CBD combined with stiripentol (used in Dravet syndrome) may produce additive CNS depression. Close monitoring is warranted.
  • Rufinamide (Banzel): CBD may increase rufinamide levels — discuss with your neurologist before starting MMJ.
  • Other AEDs: Many AEDs are metabolized by CYP enzymes that cannabis can inhibit or induce. A full medication review at your evaluation is essential.
Coordinate with your neurologist. Your Miracle Leaf physician conducts a clinical evaluation and completes your OMMU certification. Your neurologist manages your AED regimen and seizure monitoring. For epilepsy patients, both conversations need to happen — your certifying physician cannot adjust your AEDs, and your neurologist cannot complete your MMJ certification. Both roles matter.

MMJ Delivery Methods for Epilepsy Patients

Your certifying physician determines which delivery methods are clinically appropriate based on your seizure type, current AEDs, and clinical situation. For epilepsy patients, the cannabinoid profile — particularly the CBD:THC ratio — is often as important as the delivery method itself.

🫙
Tinctures & Oils — CBD-dominant
Most commonly discussed for epilepsy. Precise dose titration. CBD-dominant formulations align with the evidence base for seizure management. Sublingual or oral administration.
Most commonly used for epilepsy patients
💊
Capsules & Softgels
Pre-measured oral doses — consistent and easy to build into a daily AED regimen. Good for patients who need predictable dosing alongside existing medications.
Consistent daily dosing alongside AEDs
💨
Vaporized Products
Faster onset (2–10 min). May be appropriate for certain situations but less commonly recommended as a primary delivery method for epilepsy management.
Discuss appropriateness with your physician
🌿
Smokable Flower
Not typically the primary recommendation for epilepsy patients given the variable cannabinoid delivery and combustion byproducts. Discuss with your physician if you are interested.
Discuss with your physician first
🧴
Topicals
Non-psychoactive in most formulations. Not typically used for seizure management directly — may be appropriate for comorbid pain or inflammation.
For comorbid pain, not seizure management
Treatment-resistant epilepsy patients
If you have tried multiple AEDs without adequate seizure control, mention this at your evaluation. The clinical picture for treatment-resistant epilepsy often supports a broader discussion of cannabinoid options — including the ratio of CBD to THC — that is tailored specifically to your seizure type and medication history. Call (561) 888-6111 to discuss before your appointment.

Frequently Asked Questions

Does epilepsy qualify for a Florida medical marijuana card?

Yes. Epilepsy is explicitly listed as a qualifying condition under Florida Statute 381.986. All documented seizure disorders qualify — including generalized epilepsy, focal epilepsy, treatment-resistant epilepsy, and pediatric epilepsy syndromes such as Dravet syndrome and Lennox-Gastaut syndrome. The statute also covers conditions "of the same kind or class" as epilepsy, ensuring no seizure disorder is excluded by type.

Do all types of seizure disorders qualify for a Florida MMJ card?

Yes. Florida Statute 381.986 lists epilepsy and seizures and includes the provision for conditions "of the same kind or class." All documented seizure disorders qualify — tonic-clonic, absence, focal, myoclonic, and other seizure types, as well as treatment-resistant epilepsy syndromes.

What documentation does an epilepsy patient need for a Florida MMJ card?

You need medical records from your neurologist documenting your epilepsy or seizure disorder, your current AED medication list, and — for treatment-resistant epilepsy — documentation of prior medications tried and failed. Your most recent neurology visit note is typically sufficient as primary documentation. Bring your full medication list so your physician can review potential interactions at your evaluation.

Can a child with epilepsy get a Florida MMJ card?

Yes. Florida law allows minors with qualifying conditions to participate in the MMJ program with a parent or legal guardian registered as a caregiver. The caregiver registers with the OMMU and purchases approved products on behalf of the minor patient. Pediatric epilepsy — including Dravet syndrome and Lennox-Gastaut syndrome — was one of the primary conditions driving Florida's original medical marijuana legislation. Call us to discuss the caregiver registration process before your appointment.

What MMJ delivery methods are available for epilepsy patients in Florida?

Your certifying physician determines which delivery methods are clinically appropriate based on your seizure type, AED regimen, and clinical situation. CBD-dominant tinctures and capsules are most commonly discussed for epilepsy patients given CBD's established role in seizure management. Your physician reviews potential interactions with your current AEDs before completing your certification.

Can MMJ interact with my seizure medications?

Yes. Cannabis — particularly CBD — can interact with certain antiepileptic drugs. CBD is a known inhibitor of CYP2C19, which metabolizes clobazam. CBD may also increase valproate levels. A full medication review is a critical part of your Miracle Leaf evaluation. Do not adjust your AED doses without consulting your neurologist — your certifying physician and your neurologist both play important roles in your epilepsy management.

Ready to get certified?

Bring your neurology records and AED medication list — our physician handles the OMMU submission same day. Open 6 days a week in West Palm Beach.

Schedule Evaluation or call us first (561) 888-6111
MD
Medically reviewed by Dr. Samuel Sadow, MD
Florida Medical License #ME45344 · Certified in Cannabis Medicine · Miracle Leaf, West Palm Beach

All qualification information reflects Florida Statute 381.986 and current OMMU guidance, verified March 2026. Medication interaction information is for clinical awareness only — consult your neurologist before making any changes to your AED regimen. View full physician credentials →